FDA approves Gilead’s Veklury for Covid-19 treatment in renal impairment patients
The approval was based on findings from a Phase 1 study, as well as results from the Phase…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Jul 23
The approval was based on findings from a Phase 1 study, as well as results from the Phase…
17 Jul 23
Xpovio is said to be the first authorised selective inhibitor of the XPO1 in the world that promotes…
17 Jul 23
In the trial, ACU193 met the primary and secondary objectives in both single and multiple doses in 60…
17 Jul 23
The grant is intended to support the further development of CTR-107 (Noregen), a novel regenerative therapeutic designed to…
17 Jul 23
GHz-Class NMR, Structural Biology assisted by Artificial Intelligence, a New Scientific Software Division and Innovative Helium Solutions at…
17 Jul 23
Deenova, the undisputed leading supplier of innovative pharmacy automation solutions for healthcare facilities, is delighted to announce the…
17 Jul 23
Gustave Roussy and THERYQ announce a strategic and structuring partnership to roll out and assess FLASH technology for…
17 Jul 23
Olympus Corporation, a global medical technology company, announced publication of study data demonstrating that the minimally invasive iTind™…
17 Jul 23
Medicxi asset-centric portfolio company Versanis Bio to be acquired by Lilly to improve patient outcomes in cardiometabolic diseases.
17 Jul 23
Combined company is expected to have cash balance of approximately $170m at close, which is expected to provide…